AAAAAA

   
Results: 1-9 |
Results: 9
Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists
Authors: Paranjape, SB Thibonnier, M
Citation: Sb. Paranjape et M. Thibonnier, Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists, EXPERT OP I, 10(5), 2001, pp. 825-834
The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists
Authors: Thibonnier, M Coles, P Thibonnier, A Shoham, M
Citation: M. Thibonnier et al., The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists, ANN R PHARM, 41, 2001, pp. 175-202
Role of the human V-1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction
Authors: Thibonnier, M Plesnicher, CL Berrada, K Berti-Mattera, L
Citation: M. Thibonnier et al., Role of the human V-1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction, AM J P-ENDO, 281(1), 2001, pp. E81-E92
Mediators of the mitogenic action of human V-1 vascular vasopressin receptors
Authors: Thibonnier, M Conarty, DM Plesnicher, CL
Citation: M. Thibonnier et al., Mediators of the mitogenic action of human V-1 vascular vasopressin receptors, AM J P-HEAR, 279(5), 2000, pp. H2529-H2539
A molecular model of agonist and nonpeptide antagonist binding to the human V-1 vascular vasopressin receptor
Authors: Thibonnier, M Coles, P Conarty, DM Plesnicher, CL Shoham, M
Citation: M. Thibonnier et al., A molecular model of agonist and nonpeptide antagonist binding to the human V-1 vascular vasopressin receptor, J PHARM EXP, 294(1), 2000, pp. 195-203
Study of V-1-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension
Authors: Thibonnier, M Graves, MK Wagner, MS Chatelain, N Soubrier, F Corvol, P Willard, HF Jeunemaitre, X
Citation: M. Thibonnier et al., Study of V-1-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension, J MOL CEL C, 32(4), 2000, pp. 557-564
Dynamic interaction of human vasopressin/oxytocin receptor subtypes with Gprotein-coupled receptor kinases and protein kinase C after agonist stimulation
Authors: Berrada, K Plesnicher, CL Luo, X Thibonnier, M
Citation: K. Berrada et al., Dynamic interaction of human vasopressin/oxytocin receptor subtypes with Gprotein-coupled receptor kinases and protein kinase C after agonist stimulation, J BIOL CHEM, 275(35), 2000, pp. 27229-27237
Effects of the nonpeptide V-1 vasopressin receptor antagonist SR49059 in hypertensive patients
Authors: Thibonnier, M Kilani, A Rahman, M DiBlasi, TP Warner, K Smith, MC Leenhardt, AF Brouard, R
Citation: M. Thibonnier et al., Effects of the nonpeptide V-1 vasopressin receptor antagonist SR49059 in hypertensive patients, HYPERTENSIO, 34(6), 1999, pp. 1293-1300
Human vascular endothelial cells express oxytocin receptors
Authors: Thibonnier, M Conarty, DM Preston, JA Plesnicher, CL Dweik, RA Erzurum, SC
Citation: M. Thibonnier et al., Human vascular endothelial cells express oxytocin receptors, ENDOCRINOL, 140(3), 1999, pp. 1301-1309
Risultati: 1-9 |